NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity.

Autor: Sokolova M; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Center for Heart Failure Research, University of Oslo, Oslo, Norway.; K.G. Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway., Sjaastad I; K.G. Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway.; Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway., Louwe MC; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Center for Heart Failure Research, University of Oslo, Oslo, Norway.; K.G. Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway., Alfsnes K; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Aronsen JM; Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway.; Bjørknes College, Oslo, Norway., Zhang L; Center for Heart Failure Research, University of Oslo, Oslo, Norway.; Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway., Haugstad SB; Center for Heart Failure Research, University of Oslo, Oslo, Norway.; Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway., Bendiksen BA; Center for Heart Failure Research, University of Oslo, Oslo, Norway.; Institute for Experimental Medical Research, Oslo University Hospital Ullevål, Oslo, Norway., Øgaard J; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Bliksøen M; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Lien E; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, United States.; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Berge RK; Department of Clinical Science, Department of Heart Disease, Haukeland University Hospital, University of Bergen, Bergen, Norway., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway., Ranheim T; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Center for Heart Failure Research, University of Oslo, Oslo, Norway.; K.G. Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway., Yndestad A; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Center for Heart Failure Research, University of Oslo, Oslo, Norway.; K.G. Jebsen Center for Cardiac Research, University of Oslo, Oslo, Norway.

Publikováno v: Frontiers in immunology [Front Immunol] 2019 Jul 16; Vol. 10, pp. 1621. Date of Electronic Publication: 2019 Jul 16 (Print Publication: 2019).

Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice.

Autor: Cero FT; Department of Pulmonary Medicine, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; cero.fadila@medisin.uio.no., Hillestad V; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway;, Sjaastad I; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; K.G. Jebsen Inflammation Research Center, Faculty of Medicine, University of Oslo, Oslo, Norway;, Yndestad A; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway; K.G. Jebsen Inflammation Research Center, Faculty of Medicine, University of Oslo, Oslo, Norway;, Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway; K.G. Jebsen Inflammation Research Center, Faculty of Medicine, University of Oslo, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway;, Ranheim T; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway; K.G. Jebsen Inflammation Research Center, Faculty of Medicine, University of Oslo, Oslo, Norway;, Lunde IG; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Department of Genetics, Harvard Medical School, Boston, Massachusetts;, Olsen MB; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway;, Lien E; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts; Centre of Inflammation Research, Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway;, Zhang L; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway;, Haugstad SB; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway;, Løberg EM; Department of Pathology, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway., Christensen G; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway;, Larsen KO; Department of Pulmonary Medicine, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway; Center for Heart Failure Research, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway;, Skjønsberg OH; Department of Pulmonary Medicine, Oslo University Hospital Ullevål and University of Oslo, Oslo, Norway;

Publikováno v: American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2015 Aug 15; Vol. 309 (4), pp. L378-87. Date of Electronic Publication: 2015 Jun 12.